论文信息 - Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC). - 字舞流文

Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC).

T. Lynch | I. Bondarenko | F. Barlesi | R. Chacko | M. Reck | M. Sebastian | J. Siegel | J. Cuillerot | P. Serwatowski | A. Luft